Volume 32, Issue 3 | PharmacoEconomics

Search all PharmacoEconomics articles

Volume 32, Issue 3

March 2014

Health Economic Issues in China

Issue Editors:

Eric Q. Wu,
Lizheng Shi,
Jipan Xie

8 articles in this issue

The Role of Health Economics and Outcomes Research in Health Care Reform in China
Wannian Liang
Jipan Xie
Eric Q. Wu
Editorial Open access 20 February 2014 Pages: 231 - 234
Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer
Tan Chongqing
Peng Liubao
Zhao Ziying
Original Research Article 25 May 2013 Pages: 235 - 243
Does Economic Incentive Matter for Rational Use of Medicine? China’s Experience from the Essential Medicines Program
Mingsheng Chen
Lijie Wang
Wenhui Mao
Original Research Article 28 June 2013 Pages: 245 - 255
Time Trends and Determinants of Pharmaceutical Expenditure in China (1990–2009)
Lizheng Shi
Heidi Y. Yang
Qingyue Meng
Original Research Article 05 July 2013 Pages: 257 - 264
Impacts of Health Insurance Benefit Design on Percutaneous Coronary Intervention Use and Inpatient Costs among Patients with Acute Myocardial Infarction in Shanghai, China
Suwei Yuan
Yan Liu
Jin Ma
Original Research Article 23 August 2013 Pages: 265 - 275
The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China
Gang Chen
Gordon G. Liu
Fei Xu
Original Research Article 01 November 2013 Pages: 277 - 292
Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals
Jing Wu
Judy Xu
Jiuhong Wu
Original Research Article 05 November 2013 Pages: 293 - 303
Treatment, Monitoring, and Economic Outcomes of Venous Thromboembolism Among Hospitalized Patients in China
Eric Q. Wu
Jipan Xie
Yuanli Liu
Original Research Article 06 February 2014 Pages: 305 - 313